reference/8871993

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8871993

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't\|Review
endingPage	2923
issn	1759-7714 1759-7706
issueIdentifier	10
pageRange	2916-2923
publicationName	Thoracic Cancer
startingPage	2916
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f4c8349be1249ed10820125e428cb20f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_72820be1c4793c8fc861bd95b385285e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d7b103234646daccea81a8951b63f6ca http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a9c0ea59668a4e54e8a4fb6f34338493
bibliographicCitation	Zhang T, Xu K, Bi N, Zhang L, Jiang W, Liang J, Deng L, Wang X, Wang J, Wang J, Wang L. Efficacy and safety of immune checkpoint inhibitor consolidation after chemoradiation in patients of Asian ethnicity with unresectable stage III non‐small cell lung cancer: Chinese multicenter report and literature review. Thoracic Cancer. 2020 Aug 24;11(10):2916–23. doi: 10.1111/1759-7714.13631.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d61e7489c0730b02c1f847f777c0d9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d93a7d0d6b49a51764bfb692afd3071 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4861-0679 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc010e156a13806ae00368df24a7bacc http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9652-3284 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5919-5074 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c50882ea93225fe0a328bfd6f47f881e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7af4317a2b1e26b7667b916a23a666e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89f3098acafc7bcde459c70f5965d5da http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5602-0487
date	2020-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/1759-7714.13631 https://pubmed.ncbi.nlm.nih.gov/32833338 https://pubmed.ncbi.nlm.nih.gov/PMC7529561
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43270 https://portal.issn.org/resource/ISSN/1759-7714 https://portal.issn.org/resource/ISSN/1759-7706
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and safety of immune checkpoint inhibitor consolidation after chemoradiation in patients of Asian ethnicity with unresectable stage III non‐small cell lung cancer: Chinese multicenter report and literature review
discusses	http://id.nlm.nih.gov/mesh/M000675754
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000082082Q000627 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D044466 http://id.nlm.nih.gov/mesh/D002681 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D000082082Q000494 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Total number of triples: 58.